WATSON TO PAY $70 MIL. UP FRONT FOR HMR's RUGBY GENERIC DIVISION; HOECHST DIVESTING GENERIC DIVISIONS BEFORE NYSE LISTING SCHEDULED FOR SEPT. 24
Executive Summary
Watson Pharmaceuticals is paying $70 mil. up front to acquire the Rugby generic business from Hoechst Marion Roussel, the companies announced Aug. 26.
You may also be interested in...
Hoechst Sells Copley Stake To Teva For One-Fifth Of 1993 Purchase Price
Hoechst has completed its exit from the generic pharmaceutical industry by agreeing to sell its stake in Copley to Teva-USA for $114 mil.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011